Resource Hub
VIRTUAL TOUR
CONTACT US
Our Company
About Us
Our Journey
Leadership
Scientific and BD Team
Aragen Advantage
Global Locations
Media & Events
Recognitions
Services
Small Molecules
Discovery
Integrated Drug Discovery
Chemistry
Biology
BioSafety
Development & Manufacturing
Drug Substance
Drug Product
Analytical Development
Performance Chemicals
Custom Chemical Synthesis
Commercial Manufacturing
Large Molecules (Biologics)
Discovery
Integrated Discovery
Biology
Molecular Biology
Antibody Discovery
Protein Sciences
Cell Line Development
Development & Manufacturing
Process Research & Development
Bioproduction
Developability & Analytics
GMP Manufacturing
Investors
Annual Reports and Annual Returns
Corporate Governance
Our Responsibility
Digital & AI (DnA)
EHS & Sustainability
Strategic Supply Chain Management
Quality
IP Protection & Data Security
Employee Welfare
Corporate Social Responsibility
Corporate Governance
Careers
Working at Aragen
Career Opportunities
Meet Our People
Caution Notice
Virtual Tour
Resources
Close Search
Search
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
GET IN TOUCH
Home
Financial Statements of Subsidiaries
Financial Statements of Subsidiaries
2022
2023
2024
Aragen Bioscience Inc.
Aragen Life Sciences B.V.
Intox Private Limited
Aragen Foundation
Aragen Bioscience Inc.
Aragen Life Sciences B.V.
Intox Private Limited
Aragen Foundation
Aragen Biologics Private Limited
Intox Private Limited
Aragen Foundation
Aragen Life Sciences B.V.
Aragen Bioscience Inc
Learn more about our end-to-end capabilities
+
+
Optimized by Seraphinite Accelerator
Turns on site high speed to be attractive for people and search engines.
Optimized by Seraphinite Accelerator
